Decoy Therapeutics DCOY
NASDAQ DCOY
$2.13 -0.18 (-7.79%)
At close: Sep 29, 2026 · 4:00 PM EDT

Decoy Therapeutics (DCOY) Debt Ratio (2019 - 2025)

Updated

Decoy Therapeutics' Debt Ratio came in at 0.05 for Q1 2025, up 100.5% from 0.02 a year earlier but down 34.6% from the prior quarter.

Analysis

Decoy Therapeutics (DCOY) Debt Ratio (2019 - 2025) Analysis & Trends

For FY2024, Decoy Therapeutics' Debt Ratio was 0.07, up 61.1% from FY2023.

  • Going back by year, Debt Ratio was 0.05 in FY2023 and 0.02 in FY2020 (-44.5%).
  • The five-year range for quarterly Debt Ratio is 0.00 (Q1 2021) to 0.09 (Q3 2024).
  • Year-over-year, Debt Ratio has increased for three consecutive quarters.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Decoy Therapeutics 1.23 Mn 1.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 0.05
Dec 31, 2024 0.07
Sep 30, 2024 0.09
Mar 31, 2024 0.02
Dec 31, 2023 0.05
Sep 30, 2023 0.06
Mar 31, 2021 0.00
Dec 31, 2020 0.02
Sep 30, 2020 0.03
Mar 31, 2020 0.01
Dec 31, 2019 0.04
Sep 30, 2019 0.05
API Access

Decoy Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=DCOY&period=max&api_key=YOUR_API_KEY